24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Alphabet, Clorox, Costco, FedEx and UPS.
ProQR Therapeutics shares jumped early on Thursday after the firm announced that it received an approval from the FDA for its autosomal dominant retinitis pigmentosa drug.
ProQR Therapeutics shares made a massive gain early on Wednesday after the firm announced positive interim results from its Phase 1/2 clinical trial in patients with Leber's congenital amaurosis 10.
Shares of ProQR Therapeutics jumped early on Thursday after the company announced results from its cystic fibrosis study.
What may be the world’s largest-ever initial public offering is about to begin trading Friday, and the anticipation might suck all the air out of the IPO room.
Now that it is finally here, the coming week’s initial public offering for China’s Alibaba is anything but anti-climactic.